Award
NIH Reporter #3U19CA264504-05S1
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
Recipient
Brigham and Women's Hospital
Award Amount
$927,126.00
Ceiling
$927,126.00
Awarded
September 17, 2026
Identifier
3U19CA264504-05S1
Research grant awarded to Harvard and Stanford for developing novel targeted therapeutics for glioblastoma, focusing on pediatric and young adult populations.
Description
This is a research grant opportunity for projects related to glioma therapeutics, with a focus on pediatric and young adult populations. The project involves multiple research projects and clinical trials, with collaboration between Harvard and Stanford.